Anacardio logo
VerifiedBiotechnology Research

Anacardio

AnaCardio AB is a privately held clinical stage biopharmaceutical company developing novel drugs to treat heart failure. AnaCardio was founded based on ground-breaking research from Karolinska Institutet showing improved contractility of the heart muscle through a unique and differentiated mechanism. The Company’s lead program AC01, a first-in-class calcium sensitizing inotrope, is an oral ghrelin mimetic small-molecule, which was in-licensed from Helsinn and is now being developed as a contractile agent in heart failure patients. The company has raised over USD 40 million to date. AnaCardio is based in Stockholm, Sweden. You can find more information about AnaCardio at

7-day free trial · no credit card

HeadquartersSolna, SwedenEmployees26(1 to 10)Websiteanacardio.comLinkedIn profileLinkedIn

Verified contacts

14

available on Kipplo

LinkedIn employees

26

1 to 10 range

Open roles

no listings

Distinct roles

10

indexed titles

Tech stack

1

tools in use

Monthly traffic

organic / mo

Sign up free to see all 14 verified contacts at Anacardio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

14 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Anacardio

10 distinct titles indexed · top 10 shown.

  • 2- - ä ö
  • 1board observer
  • 1business controller
  • 1chief development officer (cdo)
  • 1chief medical officer
  • 1chief operating officer
  • 1clinical operations manager
  • 1clinical specialist
  • 1office manager
  • 1principal

Sign up to unlock all 14 contacts at Anacardio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 14 verified contacts at Anacardio

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Anacardio | Kipplo Discover